Stockreport

Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the pricing of a registered direct offering o [Read more]